Basiliximab

Common brands: Simulect, Prograf, Envarsus Xr, Tacrolimus, Cellcept

Top reporter: Novartis Pharmaceuticals Corporation

Interleukin-2 Receptor Blocking Antibody [EPC]Calcineurin Inhibitor Immunosuppressant [EPC]Corticosteroid [EPC]Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]Kinase Inhibitor [EPC]
11,495
Total Reports
5,585
Serious Reports
2,448
Death Reports
30
Reported Reactions
Death Report Ratio: High (21.30%)

Patient Demographics

Male
6,209
Female
3,655

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Basiliximab.

# Reaction Reports % of Total
1 OFF LABEL USE 965
7.0%
2 CYTOMEGALOVIRUS INFECTION 904
6.5%
3 DRUG INEFFECTIVE 889
6.4%
4 TRANSPLANT REJECTION 851
6.1%
5 KIDNEY TRANSPLANT REJECTION 768
5.5%
6 PYREXIA 611
4.4%
7 PRODUCT USE IN UNAPPROVED INDICATION 536
3.9%
8 BLOOD CREATININE INCREASED 511
3.7%
9 DIARRHOEA 500
3.6%
10 RENAL IMPAIRMENT 460
3.3%
11 ANAEMIA 436
3.1%
12 ACUTE KIDNEY INJURY 421
3.0%
13 SEPSIS 419
3.0%
14 MULTIPLE ORGAN DYSFUNCTION SYNDROME 410
3.0%
15 THROMBOTIC MICROANGIOPATHY 396
2.9%
16 PNEUMONIA 393
2.8%
17 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 384
2.8%
18 URINARY TRACT INFECTION 375
2.7%
19 LEUKOPENIA 366
2.6%
20 NEUTROPENIA 356
2.6%
21 COMPLICATIONS OF TRANSPLANTED KIDNEY 348
2.5%
22 TOXICITY TO VARIOUS AGENTS 341
2.5%
23 RESPIRATORY FAILURE 329
2.4%
24 THROMBOCYTOPENIA 293
2.1%
25 BK VIRUS INFECTION 290
2.1%
26 CYTOMEGALOVIRUS VIRAEMIA 287
2.1%
27 PANCYTOPENIA 263
1.9%
28 SEPTIC SHOCK 263
1.9%
29 RENAL TUBULAR NECROSIS 261
1.9%
30 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 256
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.